BioSpace News Archive

KA Imaging Unveils New Brand Identity for Its Patented Dual Energy Technology

Spectral DR ™ is built into the Reveal™ 35C detector and family of products.

June 22, 2022
·
2 min read
BioMidwest

Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference

Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference.

June 22, 2022
·
1 min read
Genetown

BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference

BrainsWay Ltd. announced that Christopher von Jako, PhD, BrainsWay’s President, and Chief Executive Officer, will participate in a fireside chat and panel discussion at the H.C. Wainwright 1st Annual Mental Health Conference being held at the Lotte New York Palace Hotel on June 27, 2022.

June 22, 2022
·
1 min read
Business

Delfi Diagnostics Appoints Jacob Van Naarden to its Board of Directors

Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection and monitoring, appointed Jacob Van Naarden , Senior Vice President of Eli Lilly and Company and CEO of Loxo@Lilly, to its board of directors.

June 22, 2022
·
1 min read
Business

Ligandal Partners With Nanotronics to Solidify Optimization and Quality in Personalized Genomic Medicine Delivery Systems

Ligandal Inc today announced a partnership to commercialize, develop, and provide next-generation technologies for gene therapy, peptide materials, nanomaterials, and characterization of biological technologies.

June 22, 2022
·
5 min read
Pharm Country

Athenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree

Athenex, Inc., (NASDAQ: ATNX), today announced the signing of a definitive agreement for the sale of revenues from U.S. and European royalty and milestone interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and funds managed by Oaktree Capital Management, L.P. (“Oaktree”) for $85 million.

June 22, 2022
·
6 min read
Drug Development

VistaGen Announces Completion of PALISADE-1 Phase 3 Clinical Study of PH94B for the Acute Treatment of Social Anxiety Disorder

PALISADE Phase 3 Program focused on PH94B’s potential as a rapid-onset, acute treatment of anxiety in adults with social anxiety disorder.

June 22, 2022
·
9 min read
BioForest

Zap Energy Advances Fusion Reactor Technology With First Plasmas in Next-Generation Device and New Funding

Zap Energy has officially marked a critical engineering milestone by creating the first plasmas — the hot, dense form of matter found in stars — in FuZE-Q, their new prototype.

June 22, 2022
·
5 min read
Business

CytoDyn to Hold Webcast to Provide a Quarterly Company Update

CytoDyn Inc. announced today that Tanya Urbach, Board Chair will host an investment community webcast to provide a quarterly Company update on Thursday, June 30, 2022.

June 22, 2022
·
1 min read
Biotech Bay

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal.

June 22, 2022
·
3 min read